Hemophilia and von Willebrand disease type 2N in women with inherited coagulopathies

被引：0
作者：
Miller, CH
Kelley, L
Park, AM
Green, D
机构：
[1] CHILDRENS MEM HOSP, CHICAGO, IL 60614 USA
[2] NORTHWESTERN UNIV, SCH MED, CHICAGO, IL USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P2678 / P2678
页数：1
相关论文
共 50 条
  • [41] Modification of factor VIII-von Willebrand factor binding activity assay for diagnosis of von Willebrand disease type 2N
    Zhukov, O. S.
    Popov, J.
    Ramos, R.
    Huebner, A.
    Ruden, S.
    Sferruzza, A.
    Dlott, J.
    Sahud, M.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A139 - A139
  • [42] Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice
    Swystun, L. L.
    Georgescu, I.
    Mewburn, J.
    Deforest, M.
    Nesbitt, K.
    Hebert, K.
    Dwyer, C.
    Brown, C.
    Notley, C.
    Lillicrap, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (08) : 1607 - 1619
  • [43] Molecular assessment of FVIII binding site in von Willebrand factor gene in suspects patients of von Willebrand disease type 2N
    Damian, G. B.
    Santos, A.
    Di Migueli, Oliveira C.
    Siqueira, L.
    Prezoti, A.
    Di Paula, E.
    Bizzacchi, J.
    Ozelo, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 840 - 840
  • [44] DDAVP in patients with von Willebrand disease (VWD) type 2N and phenotype compatible with VWD type 2N.
    Casais, P
    Farias, CE
    Meschengieser, SS
    Carballo, GA
    Kempfer, AC
    Grosso, S
    Lazzari, MA
    BLOOD, 2001, 98 (11) : 80B - 80B
  • [45] Management of pregnancy complications in type 2N von Willebrand disease associated to a novel mutation
    Brennan, Y.
    Favaloro, E. J.
    Curtin, J.
    Curnow, J.
    HAEMOPHILIA, 2018, 24 (03) : E148 - E152
  • [46] Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis
    Veyradier, A.
    Caron, C.
    Ternisien, C.
    Wolf, M.
    Trossaert, M.
    Fressinaud, E.
    Goudemand, J.
    HAEMOPHILIA, 2011, 17 (06) : 944 - 951
  • [47] A commercial elisa method for identifying type 2N von Willebrand disease patients and carriers
    Casonato, A.
    Pontara, E.
    Sartorello, F.
    Cattini, M. G.
    Daidone, V
    Casonato, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 946 - 946
  • [48] Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls
    Satkunam, Natasha Amrita
    Mahlangu, Johnny
    Bidlingmaier, Christoph
    Mingot-Castellano, Maria Eva
    Chitlur, Meera B.
    Fogarty, Patrick F.
    Cuker, Adam
    Mancuso, Maria Elisa
    Holme, Pal Andre
    Grabell, Julie
    Hopman, Wilma
    Mathew, Prasad
    James, Paula D.
    BLOOD, 2016, 128 (22)
  • [49] Compound heterozygosity for type 2N and type 1 von Willebrand disease (VWD) associated with a homozygous-like type 2N VWD phenotype
    Chan, J
    Mitchell, MJ
    Brown, DA
    Bromidge, ES
    Williams, C
    Smith, MP
    Savidge, GF
    THROMBOSIS AND HAEMOSTASIS, 1999, : 558 - 558
  • [50] von Willebrand disease (vWD) type 2N in patients diagnosed to have haemophilia A or vWD type 1
    Cumming, AM
    Keeney, S
    Shanks, D
    Hay, CRM
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2682 - P2682
12345